With the changing trends at global level, cannabis is expected to play an increasingly important role in the future for various industries while the sector is highly speculative. Few of the stocks under this category are discussed in the article.
Affinity Energy and Health Limited – Formerly called, Algae.Tec Limited (ASX: AEB), Affinity Energy and Health Limited is investigating using waste carbon dioxide to produce plant products commercially, medicinal grade cannabis, algae-based nutraceuticals, biofuels and animal feed and aquaculture, a little more diversified than some of the other players here. For a breeding program that can help develop stock for the purpose of veterinary medications, and animal therapeutics etc., Algae.Tec is provided with THC Delta 9 cannabis cultivars by Medical Cannabis. To have a legal plant source and access to genetics, and hands on experience, Queensland Bauxite claims the agreement positions for Algae as one of the Australia’s few cannabis companies. With a view to having them ready for market by the end of the year, the group plans to fast-track its product research and development. The stock was trading at a current market price of $0.018 with no daily price change. The stock has seen a performance change of -40.00% over the past 12 months.
Atlas Pearls Limited (ASX: ATP) – With Atlas proficient at growing perfumes and oils in Tasmania, the idea is to have a collaborative approach with various partners bringing skills to the deal. Under the consumer discretionary segment, the company is into developing a supply chain of medicinal cannabis solutions, the jointly owned subsidiary company Cannabinoid Extracts Australia will pursue licenses. The stock was trading at a market price of $0.023 and has seen a flat daily price change. It is into pearl farming, distribution and perfume manufacture and jewelry retailing. The stock has seen a performance change of -11.54% over the past 12 months.
AusCann Group Holdings Limited (ASX: AC8) – The company is into manufacturing, cultivation and supply of medical cannabis products. AusCann has a strong relationship with Canada’s largest player, Canopy Growth, which holds AusCann shares and is fully licensed for growing and researching medicinal cannabis, the company is Based in Perth. With the usual caveat that the location of the production sites remains secret, Australian production is being ramped up near Perth. The group has now completed the pilot study of final dose form of Cannabinoid Capsules. The stock was trading at a market price of $1.030 and has seen a daily price change of $0.035 or a percentage change of 3.52%. The stock has seen a performance change of 70.09% over the past 12 months.
Bod Australia Limited (ASX: BDA) operates under distribution agreements for the two brands, Bioeffect and Dr. Roebuck’s. It is now planning to launch own-brand skincare products and natural remedies. The cannabis oil is now received and rebottled at Bod’s Australian facilities, i.e. the cannabis oil imported for which the sales will commence shortly. The stock was trading at a current market price of $0.585 and has seen a flat daily price change. The stock has seen a performance change of a staggering 317.86% over the past 12 months.
The Income available from dividends remains attractive for many investors.
We take a look at the best yields on the market and assess what they say about a company’s prospect.
One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”
ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.
Click here to get your free report.
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.